Metrion Biosciences Ltd., a specialist ion channel contract research and drug discovery company, appointed Steve Jenkinson vice president, drug discovery and safety assessment. In a statement, the company said that the appointment represents an important step in the expansion of Metrion’s business, driven by its ion channel discovery capabilities. Jenkinson will be responsible for supporting Metrion’s growing client base across the US, guiding projects, and navigating key milestones. He ha...